英文名稱(chēng) | Enlimomab |
---|---|
中文名稱(chēng) | 恩莫單抗 |
CAS號(hào) | 142864-19-5 |
儲(chǔ)存條件 | Sealed and stored at ≤-20℃, away from light. Avoid freeze-thaw cycles |
規(guī)格 | 庫(kù)存 | 目錄價(jià) | 會(huì)員專(zhuān)享價(jià) | 數(shù)量 |
---|---|---|---|---|
1 mg | 3-5days | ¥5200.00 | 登錄后可見(jiàn) | |
5 mg | 3-5days | ¥22100.00 | 登錄后可見(jiàn) | |
10 mg | 3-5days | ¥38000.00 | 登錄后可見(jiàn) | |
50 mg | 3-5days | ¥152000.00 | 登錄后可見(jiàn) | |
100 mg | 3-5days | ¥275000.00 | 登錄后可見(jiàn) |
英文名稱(chēng) | Enlimomab |
---|---|
中文名稱(chēng) | 恩莫單抗 |
CAS號(hào) | 142864-19-5 |
儲(chǔ)存條件 | Sealed and stored at ≤-20℃, away from light. Avoid freeze-thaw cycles |
Enlimomab (BI-RR 0001), a murine IgG2a monoclonal antibody to the human ICAM-1, inhibits leukocyte adhesion to the vascular endothelium, thereby decreasing leukocyte extravasation and inflammatory tissue injury. Enlimomab has anti-inflammatory effects, and can be used for stroke research .